Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tricia.rubi
    Junior Member
    • Dec 2017
    • 1

    Bismark - extract genomic sequence from SAM / BAM format?

    Hello all,

    I am working with a bisulfite-converted library and I would like to extract the original genomic sequences for my reads (in other words, I would like to convert the bisulfite sequences back to regular genomic sequences). I have been using Bismark to align my reads to a reference genome. Bismark outputs a BAM file with the following fields (copied from the user guide):

    1. QNAME*(seq-ID)
    2. FLAG*(this flag tries to take the strand a bisulfite read originated from into account (this is different from ordinary DNA alignment flags!))
    3. RNAME*(chromosome)
    4. POS*(start position)
    5. MAPQ*(only calculated for Bowtie 2, always 255 for Bowtie)
    6. CIGAR
    7. RNEXT
    8. PNEXT
    9. TLEN
    10. SEQ
    11. QUAL*(Phred33 scale)
    12. NM-tag*(edit distance to the reference)
    13. MD-tag*(base-by-base mismatches to the reference)
    14. XM-tag (methylation call string)
    15. XR-tag*(read conversion state for the alignment)
    16. XG-tag (genome conversion state for the alignment)

    Field 10 is the actual read, i.e., the bisulfite read. Field 14 specifies the methylation call at each position, so my understanding is that those fields could be used together to infer the original sequence. What I am looking for is either:

    1. A way to have Bismark output the original genomic sequence (the older version actually did this - see note below),
    2. A script that will use the BAM output to convert the bisulfite sequences to genomic sequences, or
    3. Another bisulfite aligner that offers this functionality.

    Note: The original version of Bismark actually outputs a tab-delimited text file that contains the information I want - field 7 is the "original bisulfite read sequence" and field 8 is the "equivalent genomic sequence." Bismark allows users to request this output using the --vanilla call, however, it uses the older version of Bismark, which is only compatible with bowtie1. I am getting much better alignments with the newer version which uses bowtie2 and outputs BAM files that do not contain the genomic sequence, so I would prefer not to use the --vanilla call.

    Any help would be greatly appreciated.

    Thanks,
    Tricia
  • fkrueger
    Senior Member
    • Sep 2009
    • 627

    #2
    I suggested the option of using one of several BS-SNP callers (Bis-SNP, MethylExtract or BS-SNPer) via email, so I am hoping one of them will prove useful.

    Comment

    Latest Articles

    Collapse

    • mylaser
      Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by mylaser
      Kheloyaar: The Complete Guide to Kheloyaar Loginand Kheloyaar ID
      The online gaming industry has transformed the way people enjoy digital entertainment. As technology continues to improve, players are looking for platforms that offer convenience, security, and a seamless user experience. Kheloyaarhas gained attention among users who value an easy-to-use platform, quick account access, and a simple registration process.
      Whether you're exploring Kheloyaar for the first time or want to understand...
      Today, 09:27 PM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      Today, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      Yesterday, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Today, 10:04 AM
    0 responses
    8 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:08 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-07-2026, 11:05 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-02-2026, 11:08 AM
    0 responses
    31 views
    0 reactions
    Last Post SEQadmin2  
    Working...